---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-036495"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:22:43.571878+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# X4 Pharmaceuticals posts updated corporate presentation on website

## Summary
- Presentation posted on August 8, 2024, in Investors section of www.x4pharma.com.
- No financial results, guidance, or material business updates disclosed in filing.
- Presentation content not filed with SEC; furnished under Regulation FD.
- Investors directed to company website for details; no exhibit included in filing.

## SEC filing metadata
- accession: 0001628280-24-036495
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828024036495/0001628280-24-036495-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828024036495/xfor-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-036495
- JSON: https://secwatch.observer/filing/0001628280-24-036495.json
- Plain text: https://secwatch.observer/filing/0001628280-24-036495.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.